Central - Tenders Closing By Day
States - Tenders Closing By Day

Closing Today
Closing within 7 days
Closing within 14 days
By Closing Date
Tender Calendar

Central -Tenders Closing Today

Total Tenders : 2514
Sl.No e-Published Date Bid Submission Closing Date Tender Opening Date Title/Ref.No./Tender Id State Name Corrigendum
1211. 11-Nov-2025 12:02 PM 04-Dec-2025 01:30 PM 04-Dec-2025 01:30 PM SILYMARIN 140 MG ORAL TABLET/99255174A/106879527 Ministry of Railways --
1212. 11-Nov-2025 11:59 AM 04-Dec-2025 01:30 PM 04-Dec-2025 01:30 PM SERTRALINE 50 MG ORAL TABLET/99255251A/106879697 Ministry of Railways --
1213. 11-Nov-2025 12:06 PM 04-Dec-2025 01:30 PM 04-Dec-2025 01:30 PM SERRATIOPEPTIDASE 10 MG ORAL TABLET/99255192A/106879525 Ministry of Railways --
1214. 11-Nov-2025 12:04 PM 04-Dec-2025 01:30 PM 04-Dec-2025 01:30 PM OFLOXACIN 0.3 Percent AND DEXAMETHASONE 0.1 Percent EAR DROPS 5 ML/99255124A/106879522 Ministry of Railways --
1215. 10-Nov-2025 02:46 PM 04-Dec-2025 01:30 PM 04-Dec-2025 01:30 PM Inj. Human Coagulation Factor VIII 250 IU (Antihaemophilic Factor VIII)/22251318C/106879545 Ministry of Railways --
1216. 11-Nov-2025 12:07 PM 04-Dec-2025 01:30 PM 04-Dec-2025 01:30 PM POLYETHYLENE GLYCOL + PROPYLENE GLYCOL EYE DROPS 10 ML, PRESERVATIVE-POLYQUAD/99255085B/106879520 Ministry of Railways --
1217. 11-Nov-2025 12:09 PM 04-Dec-2025 01:30 PM 04-Dec-2025 01:30 PM TENOFOVIR ALAFENAMIDE 25 MG ORAL TABLET/99255224A/106879518 Ministry of Railways --
1218. 10-Nov-2025 02:42 PM 04-Dec-2025 01:30 PM 04-Dec-2025 01:30 PM Inj. Liraglutide 6 mg/ml, 3 ml Prefilled Pen, (1 Needle free per Pen) [ ITEM CODE M150401] as per Specn. ITEM CODE M150401.AI 25-26./22251381/106879543 Ministry of Railways --
1219. 11-Nov-2025 12:10 PM 04-Dec-2025 01:30 PM 04-Dec-2025 01:30 PM RABEPRAZOLE SODIUM 20 MG ORAL TABLET/99255183A/106879516 Ministry of Railways --
1220. 11-Nov-2025 02:58 PM 04-Dec-2025 01:30 PM 04-Dec-2025 01:30 PM Set of Electrode (cathode) & Nozzle (anode)/52256899/106879463 Ministry of Railways --

Note : For more details and clarifications, please refer to the respective Portal.